Evaluate the performance of nucleic acid tests for determination of the presence of <i>Mycoplasma pneumoniae</i> nucleic acids Formulated with purified, intact organisms Organisms are chemically modified to render them noninfectious
Evaluate the performance of nucleic acid tests for determination of the presence of <i>Mycoplasma pneumoniae</i> nucleic acids Formulated with purified, intact organisms Organisms are chemically modified to render them noninfectious
ABBV-CLS-484 is a potent PTPN1 and PTPN2 inhibitor with subnanomolar activity. ABBV-CLS-484 has antitumor activity, enhances the immune response and increases the sensitivity of tumors to immune-mediated killing.In VitroABBV-CLS-484 acts on both
ABBV-CLS-484 is a potent PTPN1 and PTPN2 inhibitor with subnanomolar activity. ABBV-CLS-484 has antitumor activity, enhances the immune response and increases the sensitivity of tumors to immune-mediated killing.In VitroABBV-CLS-484 acts on both
ABBV-CLS-484 is a potent PTPN1 and PTPN2 inhibitor with subnanomolar activity. ABBV-CLS-484 has antitumor activity, enhances the immune response and increases the sensitivity of tumors to immune-mediated killing.In VitroABBV-CLS-484 acts on both
ABBV-CLS-484 is a potent PTPN1 and PTPN2 inhibitor with subnanomolar activity. ABBV-CLS-484 has antitumor activity, enhances the immune response and increases the sensitivity of tumors to immune-mediated killing.In VitroABBV-CLS-484 acts on both